• Keytruda-chemotherapy combination gets CHMP nod pharmatimes
    July 31, 2018
    MSD’s Keytruda may become the first anti-PD-1 drug in Europe to be approved in combination with chemotherapy, following a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP).
PharmaSources Customer Service